Gitte Berkers

1.5k total citations · 1 hit paper
17 papers, 650 citations indexed

About

Gitte Berkers is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Physiology. According to data from OpenAlex, Gitte Berkers has authored 17 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 2 papers in Genetics and 2 papers in Physiology. Recurrent topics in Gitte Berkers's work include Cystic Fibrosis Research Advances (13 papers), Neonatal Respiratory Health Research (7 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Gitte Berkers is often cited by papers focused on Cystic Fibrosis Research Advances (13 papers), Neonatal Respiratory Health Research (7 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Gitte Berkers collaborates with scholars based in Netherlands, United States and United Kingdom. Gitte Berkers's co-authors include Cornelis K. van der Ent, Jeffrey M. Beekman, Annelotte M. Vonk, Hugo R. de Jonge, Johanna F. Dekkers, Evelien Kruisselbrink, Hettie M. Janssens, Harry Heijerman, Roderick H.J. Houwen and Karin M. de Winter‐de Groot and has published in prestigious journals such as PLoS ONE, Science Translational Medicine and European Respiratory Journal.

In The Last Decade

Gitte Berkers

17 papers receiving 641 citations

Hit Papers

Characterizing responses to CFTR-modulating drugs using r... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
    2016 401 citations Johanna F. Dekkers, Gitte Berkers et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gitte Berkers Netherlands 10 401 182 135 125 70 17 650
Anjali Jacob United States 6 445 1.1× 387 2.1× 130 1.0× 77 0.6× 258 3.7× 11 755
Sunny Xia Canada 10 190 0.5× 113 0.6× 35 0.3× 30 0.2× 101 1.4× 14 386
Autumn Ferguson United States 6 92 0.2× 264 1.5× 217 1.6× 117 0.9× 160 2.3× 7 653
William P. Shield United States 10 131 0.3× 89 0.5× 35 0.3× 62 0.5× 76 1.1× 14 381
John L. Burns United States 10 81 0.2× 171 0.9× 35 0.3× 42 0.3× 125 1.8× 17 510
Aaron P. Garrison United States 11 70 0.2× 101 0.6× 20 0.1× 152 1.2× 147 2.1× 35 400
Yuki Yamamoto Japan 5 306 0.8× 216 1.2× 65 0.5× 23 0.2× 166 2.4× 9 462
So Jeong Lee South Korea 12 123 0.3× 74 0.4× 41 0.3× 204 1.6× 130 1.9× 52 447
Birgitt Wolfesberger Austria 14 220 0.5× 92 0.5× 15 0.1× 47 0.4× 45 0.6× 35 423
Jaime Valentín Spain 15 80 0.2× 136 0.7× 25 0.2× 359 2.9× 17 0.2× 25 710

Countries citing papers authored by Gitte Berkers

Since Specialization
Citations

This map shows the geographic impact of Gitte Berkers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gitte Berkers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gitte Berkers more than expected).

Fields of papers citing papers by Gitte Berkers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gitte Berkers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gitte Berkers. The network helps show where Gitte Berkers may publish in the future.

Co-authorship network of co-authors of Gitte Berkers

This figure shows the co-authorship network connecting the top 25 collaborators of Gitte Berkers. A scholar is included among the top collaborators of Gitte Berkers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gitte Berkers. Gitte Berkers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mourik, Peter van, Annelotte M. Vonk, Johanna Pott, et al.. (2024). Centralized intestinal organoid generation is a feasible and safe approach for personalized medicine as demonstrated in the HIT-CF Europe Organoid Study. Journal of Cystic Fibrosis. 23(4). 703–706. 7 indexed citations
2.
Meer, Renske van der, et al.. (2021). Breast development in a 7 year old girl with CF treated with ivacaftor: An indication for personalized dosing?. Journal of Cystic Fibrosis. 20(5). e63–e66. 7 indexed citations
3.
Groot, Karin M. de Winter‐de, Gitte Berkers, Mei Ling J. N. Chu, et al.. (2021). Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N Mutation. Journal of Personalized Medicine. 11(5). 350–350. 14 indexed citations
4.
Berkers, Gitte, Renske van der Meer, Peter van Mourik, et al.. (2020). Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation. Journal of Cystic Fibrosis. 19(6). 955–961. 12 indexed citations
5.
Stegeman, Inge, et al.. (2020). The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients. PLoS ONE. 15(7). e0235638–e0235638. 14 indexed citations
6.
Berkers, Gitte, Renske van der Meer, Harry Heijerman, et al.. (2020). Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E–CFTR mutation. Journal of Cystic Fibrosis. 20(5). 761–767. 12 indexed citations
7.
Berkers, Gitte, et al.. (2020). Long‐term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation. Pediatric Pulmonology. 55(6). 1400–1405. 5 indexed citations
8.
Berkers, Gitte, Renske van der Meer, Annelotte M. Vonk, et al.. (2019). Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations. Journal of Cystic Fibrosis. 19(4). 614–619. 38 indexed citations
9.
Janssens, Hettie M., Johanna F. Dekkers, Gitte Berkers, et al.. (2018). Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function. European Respiratory Journal. 52(3). 1702529–1702529. 51 indexed citations
10.
Peppel, Ivo P. van de, Gitte Berkers, Hugo R. de Jonge, et al.. (2018). IVACAFTOR restores FGF19 regulated bile acid homeostasis in cystic fibrosis patients with an S1251N or a G551D gating mutation. Journal of Cystic Fibrosis. 18(2). 286–293. 25 indexed citations
11.
Berkers, Gitte, Johanna F. Dekkers, Evelien Kruisselbrink, et al.. (2017). Correlation between individual clinical responses and forskolin-induced swelling of paired intestinal organoids upon CFTR modulator treatment. Pediatric Pulmonology. 52. 1 indexed citations
12.
Mourik, Peter van, Gitte Berkers, Annelotte M. Vonk, et al.. (2017). 29 Validating the organoid model across European laboratories. Journal of Cystic Fibrosis. 16. S70–S71. 1 indexed citations
13.
Dekkers, Johanna F., Peter van Mourik, Annelotte M. Vonk, et al.. (2016). Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutations. Journal of Cystic Fibrosis. 15(5). 568–578. 33 indexed citations
14.
Berkers, Gitte, et al.. (2016). The effect of treatment with ivacaftor on the respiratory microbial composition in the upper and lower airways. Pediatric Pulmonology. 51. 306–306. 1 indexed citations
15.
Berkers, Gitte, Johanna F. Dekkers, Domenique D. Zomer-van Ommen, et al.. (2016). β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis. European Respiratory Journal. 48(3). 768–779. 27 indexed citations
16.
Dekkers, Johanna F., Gitte Berkers, Evelien Kruisselbrink, et al.. (2016). Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis. Science Translational Medicine. 8(344). 344ra84–344ra84. 401 indexed citations breakdown →
17.
Berkers, Gitte, et al.. (2015). [Disciplinary verdicts in cases of child abuse; lessons for paediatricians].. PubMed. 159. A8509–A8509. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anjali Jacob Breakdown of academic impact, for papers by Sunny Xia Breakdown of academic impact, for papers by Autumn Ferguson Breakdown of academic impact, for papers by William P. Shield Breakdown of academic impact, for papers by John L. Burns Breakdown of academic impact, for papers by Aaron P. Garrison Breakdown of academic impact, for papers by Yuki Yamamoto Breakdown of academic impact, for papers by So Jeong Lee Breakdown of academic impact, for papers by Birgitt Wolfesberger Breakdown of academic impact, for papers by Jaime Valentín
Rankless by CCL
2026